Reportlinker Adds Medical Imaging Reagents and Analysis Equipment
NEW YORK, Jan. 4 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Medical Imaging Reagents and Analysis Equipment
http://www.reportlinker.com/p0170501/Medical-Imaging-Reagents-and-Analysis-Equipment.html
THIS REPORT
Examine the supporting products that have enhanced imaging at the chemical level (reagents and contrast media) and at the analysis level (software tools and image management)
Provide market data for 2008 and 2009, and forecast the compound annual growth rate (CAGR) for the period 2009-2014
Explain how existing medical imaging modalities such as magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), and nuclear medicine are finding new applications through the development of specialized imaging reagents
Assess the major medical applications, market players, recent patents, and emerging technologies in reagents, analysis, and image management
Chapter- 1: INTRODUCTION -- Complimentary
STUDY OBJECTIVES 1
REASONS FOR DOING THIS STUDY 1
INTENDED AUDIENCE 2
SCOPE OF THE STUDY 2
METHODOLOGY 2
INFORMATION SOURCES 2
ABOUT THE AUTHOR 2
RELATED BCC RESEARCH REPORTS 3
BCC ONLINE SERVICES 3
DISCLAIMER 3
Chapter-2: SUMMARY
SUMMARY 4
SUMMARY TABLE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND SYSTEMS), THROUGH 2014 ($ MILLIONS) 5
SUMMARY FIGURE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND SYSTEMS), 2007-2014 ($ MILLIONS) 6
Chapter-3: OVERVIEW
WHAT IS MEDICAL IMAGING 7
HISTORY OF MEDICAL IMAGING 7
TABLE 1 HISTORY OF MEDICAL IMAGING, 1895-1993 7
TYPES OF MEDICAL IMAGING 8
X-RAY IMAGING 8
Applications of X-ray in Medicine 8
TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY IMAGING 9
ULTRASOUND 9
Applications of Ultrasound 9
TABLE 3 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND 10
MAGNETIC RESONANCE IMAGING 10
Applications of Magnetic Resonance Imaging 11
TABLE 4 ADVANTAGES AND DISADVANTAGES OF MAGNETIC RESONANCE IMAGING 11
COMPUTED TOMOGRAPHY 12
Applications of Computed Tomography 12
TABLE 5 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY 13
POSITRON EMISSION TOMOGRAPHY 13
Applications of Positron Emission Tomography 14
TABLE 6 ADVANTAGES AND DISADVANTAGES OF POSITRON EMISSION TOMOGRAPHY 14
DIFFERENTIATION BETWEEN VARIOUS IMAGING TECHNIQUES 15
TABLE 7 DIFFERENCES BETWEEN CT AND PET 15
TABLE 8 DIFFERENCES BETWEEN CT AND MRI 15
CONTRAST AGENTS OR IMAGING REAGENTS 15
PROPERTIES OF AN IDEAL CONTRAST AGENT 16
CLASSIFICATION OF CONTRAST AGENTS BASED ON THEIR PROPERTIES 16
Positive Contrast Agents 16
Barium 16
Iodine-based Contrast Agents 17
Negative Contrast Agents 17
CLASSIFICATION OF CONTRAST AGENTS BASED ON THE TYPE OF IMAGING TECHNIQUE 17
Contrast Agents for X-Ray 18
Contrast Agents for Magnetic Resonance Imaging 18
Contrast Agents for Ultrasound 19
PET Radiopharmaceuticals 19
TABLE 9 COMPOUNDS USED IN PET SCAN 20
IMAGING EQUIPMENT 20
X-RAY IMAGING SYSTEM 20
FLUOROSCOPY EQUIPMENT 21
COMPUTED TOMOGRAPHY SCANNER 21
ULTRASOUND MACHINES 22
Bedside Doppler 23
Duplex Doppler 23
Color Doppler 23
Power Doppler 23
MAGNETIC RESONANCE IMAGING SYSTEM 24
Conventional MRI Units 24
Short-bore MRI Units 25
Open MRI Units 25
Mobile MRI Units 25
Dedicated Extremity/Head/Breast MRI units 25
POSITRON EMISSION TOMOGRAPHY EQUIPMENT 25
Chapter-4: REGULATORY ASPECTS
COMPUTED TOMOGRAPHY 26
ULTRASOUND 27
POSITRON EMISSION TOMOGRAPHY 27
NEED FOR CHANGE IN CURRENT GOOD MANUFACTURING PRACTICES REQUIREMENTS 28
APPROVALS IN THE FIELD OF MEDICAL IMAGING 28
TABLE 10 APPROVALS OF IMAGING AGENTS: 2006 THROUGH SEPTEMBER 2009 28
TABLE 11 APPROVALS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 29
TABLE 12 RECALLS OF IMAGING REAGENTS: 2006 THROUGH SEPTEMBER 2009 29
TABLE 13 RECALLS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 29
Chapter-5: INDUSTRY STRUCTURE
MANUFACTURERS/ PRODUCTS FOR CONTRAST AGENTS/ IMAGING REAGENTS 30
TABLE 14 LEADING MANUFACTURERS OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS 30
TABLE 14 (CONTINUED) 31
TABLE 15 LEADING MANUFACTURERS OF ULTRASOUND CONTRAST AGENTS 31
TABLE 16 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS 31
TABLE 16 (CONTINUED) 32
TABLE 17 LEADING MANUFACTURERS OF RADIOPHARMACEUTICALS 32
TABLE 17 (CONTINUED) 33
TABLE 17 (CONTINUED) 34
MANUFACTURERS/ PRODUCTS FOR IMAGING SYSTEMS/ EQUIPMENT 34
TABLE 18 LEADING MANUFACTURERS OF RADIOGRAPHY (X-RAY, FLUOROSCOPY AND MAMMOGRAPHY) IMAGING SYSTEMS 34
TABLE 18 (CONTINUED) 35
TABLE 19 LEADING MANUFACTURERS OF COMPUTED TOMOGRAPHY SYSTEMS 36
TABLE 20 LEADING MANUFACTURERS OF ULTRASOUND IMAGING SYSTEMS 36
TABLE 20 (CONTINUED) 37
TABLE 20 (CONTINUED) 38
TABLE 21 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING SYSTEMS 39
TABLE 22 LEADING MANUFACTURERS OF POSITRON EMISSION TOMOGRAPHY SYSTEMS 40
MARKET SHARES OF INDUSTRY LEADERS 40
CONTRAST AGENTS/ IMAGING REAGENTS 40
X-Ray and Computed Tomography Reagents 40
TABLE 23 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2009 (%) 41
FIGURE 1 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2009 (%) 41
Ultrasound Contrast Agents 42
TABLE 24 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 42
FIGURE 2 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 (%) 42
Magnetic Resonance Imaging Agents 43
TABLE 25 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS, 2009 (%) 43
FIGURE 3 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS, 2009 (%) 43
Radiopharmaceuticals 44
TABLE 26 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) 44
FIGURE 4 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) 44
IMAGING SYSTEMS/ EQUIPMENT 45
X-Ray Imaging Systems 45
TABLE 27 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) 45
FIGURE 5 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) 45
Computed Tomography Imaging Systems 46
TABLE 28 GLOBAL MARKET SHARES OF COMPUTED TOMOGRAPHY IMAGING SYSTEMS, 2009 (%) 46
FIGURE 6 GLOBAL MARKET SHARES OF COMPUTED X-RAY IMAGING SYSTEMS, 2009 (%) 46
Ultrasound Imaging Systems 47
TABLE 29 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) 47
FIGURE 7 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) 47
Magnetic Resonance Imaging Systems 48
TABLE 30 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009 (%) 48
FIGURE 8 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009 (%) 48
Positron Emission Tomography Imaging Systems 49
TABLE 31 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY SYSTEMS, 2009 49
FIGURE 9 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS, 2009 (%) 49
Chapter-6: NEW DEVELOPMENTS
ULTRASOUND 50
TABLE 32 NEW DEVELOPMENTS IN THE FIELD OF ULTRASOUND IMAGING, 2007-2009 50
TABLE 32 (CONTINUED) 51
TABLE 32 (CONTINUED) 52
MAGNETIC RESONANCE IMAGING 52
TABLE 33 NEW DEVELOPMENTS IN THE FIELD OF MAGNETIC RESONANCE IMAGING 52
TABLE 33 (CONTINUED) 53
COMPUTED TOMOGRAPHY 53
TABLE 34 NEW DEVELOPMENTS IN THE FIELD OF COMPUTED TOMOGRAPHY IMAGING 53
X-RAY SYSTEMS 54
TABLE 35 NEW DEVELOPMENTS IN THE FIELD OF X-RAY IMAGING 54
POSITRON EMISSION TOMOGRAPHY 54
TABLE 36 NEW DEVELOPMENTS IN THE FIELD OF POSITRON EMISSION TOMOGRAPHY IMAGING 54
Chapter-7: MARKETS
IMAGING REAGENTS/ CONTRAST AGENTS 55
X-RAY AND CT CONTRAST AGENTS 55
Market Overview 55
Market Revenue 56
TABLE 37 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) 56
FIGURE 10 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) 57
Market Shares 57
TABLE 38 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 58
FIGURE 11 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 58
ULTRASOUND CONTRAST AGENTS 58
Market Overview 59
Market Revenue 60
TABLE 39 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) 60
FIGURE 12 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) 60
Market Share 61
TABLE 40 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 61
FIGURE 13 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 62
MRI CONTRAST AGENTS 62
Market Overview 62
Market Overview (Continued) 63
Market Revenue 64
TABLE 41 GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) 64
FIGURE 14 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) 64
Market Share 65
TABLE 42 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 65
FIGURE 15 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 65
RADIOPHARMACEUTICALS 66
Market Overview 66
Market Revenue 67
TABLE 43 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, THROUGH 2014 ($ MILLIONS) 67
FIGURE 16 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, 2007-2014 ($ MILLIONS) 67
Market Share 68
TABLE 44 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68
FIGURE 17 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68
IMAGING SYSTEMS/ EQUIPMENT 69
X-RAY IMAGING SYSTEMS 69
Market Overview 69
Market Revenue 70
TABLE 45 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 70
FIGURE 18 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 70
Market Share 71
TABLE 46 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71
FIGURE 19 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71
COMPUTED TOMOGRAPHY IMAGING SYSTEMS 72
Market Overview 72
Market Revenue 73
TABLE 47 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 73
FIGURE 20 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 73
Market Share 74
TABLE 48 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 74
FIGURE 21 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 74
ULTRASOUND IMAGING SYSTEMS 75
Market Overview 75
Market Revenue 76
TABLE 49 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 76
FIGURE 22 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 76
Market Share 77
TABLE 50 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 77
FIGURE 23 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 77
MAGNETIC RESONANCE IMAGING SYSTEMS 78
Market Overview 78
Market Revenue 79
TABLE 51 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 79
FIGURE 24 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 79
Market Share 80
TABLE 52 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 80
FIGURE 25 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 80
POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS 80
Market Overview 81
Market Revenue 82
TABLE 53 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY REGION THROUGH 2014 ($ MILLIONS) 82
FIGURE 26 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 82
Market Share 83
TABLE 54 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 83
FIGURE 27 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 83
Chapter-8: MARKET BY APPLICATIONS
MARKET SHARE OF APPLICATIONS 84
TABLE 55 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) 85
FIGURE 28 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) 85
CARDIOVASCULAR DISEASE DIAGNOSIS 85
MARKET REVENUE 86
TABLE 56 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, THROUGH 2014 ($ MILLIONS) 86
FIGURE 29 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2007-2014 ($ MILLIONS) 87
MARKET SHARE 87
TABLE 57 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2009 (%) 87
FIGURE 30 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2009 (%) 88
ONCOLOGY DISEASE DIAGNOSIS 88
MARKET REVENUE 89
TABLE 58 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER, THROUGH 2014 ($ MILLIONS) 89
FIGURE 31 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER, 2007-2014 ($ MILLIONS) 90
MARKET SHARE 90
TABLE 59 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER, 2009 (%) 90
FIGURE 32 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER, 2009 (%) 91
CENTRAL NERVOUS SYSTEM DIAGNOSIS 91
MARKET REVENUE 92
TABLE 60 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, THROUGH 2014 ($ MILLIONS) 92
FIGURE 33 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2007-2014 ($ MILLIONS) 93
MARKET SHARE 93
TABLE 61 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2009 (%) 93
FIGURE 34 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2009 (%) 94
GASTROINTESTINAL (GI) SYSTEM DIAGNOSIS 94
MARKET REVENUE 95
TABLE 62 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, THROUGH 2014 ($ MILLIONS) 95
FIGURE 35 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2007-2014 ($ MILLIONS) 95
MARKET SHARE 96
TABLE 63 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2009 (%) 96
FIGURE 36 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2009 (%) 96
OTHERS 97
MARKET REVENUE 97
TABLE 64 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER DISEASES, THROUGH 2014 ($ MILLIONS) 97
FIGURE 37 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER DISEASES, 2007-2014 ($ MILLIONS) 97
MARKET SHARE 98
TABLE 65 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER DISEASES, 2009 (%) 98
FIGURE 38 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER DISEASES, 2009 (%) 98
Chapter-9: PATENT ANALYSIS
PATENT ANALYSIS 99
PATENTS BY YEAR 99
TABLE 66 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 100
FIGURE 39 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 (NUMBER) 100
FIGURE 40 NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, 2005-2009 (%) 101
PATENTS BY TYPE 101
TABLE 67 PATENTS BY TYPE FOR CONTRAST AGENTS, 2005-2009 (NUMBER) 102
FIGURE 41 PATENTS BY TYPE OF CONTRAST AGENT, 2005-2009 (NUMBER) 102
TABLE 68 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) 103
FIGURE 42 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) 103
PATENTS BY COMPANY 103
TABLE 69 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009 (NUMBER) 104
FIGURE 43 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009 (NUMBER) 104
TABLE 70 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009 105
FIGURE 44 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009 106
PATENTS BY COUNTRY 106
TABLE 71 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 107
FIGURE 45 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 107
TABLE 72 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) 108
FIGURE 46 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) 108
TABLE 73 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 109
FIGURE 47 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 109
TABLE 74 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) 110
FIGURE 48 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) 110
PATENTS BY ASSIGNEE 110
TABLE 75 NUMBER OF PATENTS BY ASSIGNEE TYPE FOR CONTRAST AGENTS, 2005-2009 111
FIGURE 49 NUMBER OF PATENTS BY ASSIGNEE TYPE FOR CONTRAST AGENTS, 2005-2009 111
TABLE 76 PATENTS BY ASSIGNEE TYPE FOR IMAGING SYSTEMS, 2005-2009 112
FIGURE 50 PATENTS BY ASSIGNEE TYPE FOR IMAGING SYSTEMS, 2005-2009 112
Chapter-10: CURRENT SITUATION OF IMAGING MARKET
CONTRAST AGENT MARKET SITUATION 113
IMAGING SYSTEMS MARKET SITUATION 113
IMAGING SYSTEMS MARKET ... (CONTINUED) 114
IMAGING SYSTEMS MARKET ... (CONTINUED) 115
FACTORS AFFECTING THE IMAGING MARKET 116
REGULATORY ACTIONS 116
AGING POPULATION 116
COMPETITION 116
TECHNOLOGICAL ADVANCEMENTS 117
SETBACKS IN INDUSTRY 117
Chapter-11: COMPANY PROFILES
ALOKA CO. LTD. 118
AMAG PHARMACEUTICALS INC. 118
ANALOGIC CORPORATION 119
BAYER HEALTHCARE PHARMACEUTICALS 119
COVIDIEN 120
ECHOSON SA (PL) 121
ESAOTE S.P.A 121
E-Z-EM INC 122
FONAR CORPORATION 122
GE HEALTHCARE MEDICAL DIAGNOSTICS 123
GUERBET LLC 124
HITACHI MEDICAL SYSTEMS AMERICA INC 124
HOLOGIC INC 125
IN VIVO CORPORATION 125
LANTHEUS MEDICAL IMAGING 126
BLDG. 200-2 126
MALLINCKRODT 126
MDS NORDION 127
MEDISON AMERICA INC 127
MILLENNIUM TECHNOLOGIES LTD. 128
ONI MEDICAL SYSTEMS INC. 128
PARADIGM MEDICAL INDUSTRIES 129
PARAMED MEDICAL SYSTEMS INC. 129
PHILIPS HEALTHCARE 129
POSITRON CORPORATION 130
SHIMADZU CORPORATION 131
SIEMENS AG 131
SONOSITE INC 132
TELEMED LTD. 133
TERASON ULTRASOUND 133
TIME MEDICAL INC 134
TOMTEC IMAGING SYSTEMS 134
TOSHIBA AMERICA INC 135
TRIAD ISOTOPES INC 135
ULTRASONIX MEDICAL CORP. 136
VOLCANO CORPORATION 137
ZONARE MEDICAL SYSTEMS INC. 137
APPENDIX: ABBREVIATIONS 138
To order this report:
Chemical Industry: Medical Imaging Reagents and Analysis Equipment
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article